| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/22/2009 | US20090023713 Heterocyclic compounds |
| 01/22/2009 | US20090023711 Piperazines and Piperidines as Mglur5 Potentiators |
| 01/22/2009 | US20090023710 Compound |
| 01/22/2009 | US20090023709 Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase |
| 01/22/2009 | US20090023708 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses |
| 01/22/2009 | US20090023702 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | US20090023701 Cytokine Inhibitors |
| 01/22/2009 | US20090022796 Novel Substituted Benzimidazole Dosage Forms and Method of Using Same |
| 01/22/2009 | US20090022670 Novel compounds |
| 01/22/2009 | US20090021146 Organic compound, charge transport material and organic electroluminescent device |
| 01/22/2009 | DE102006014320B4 Inhibitoren der löslichen Adenylatzklase Inhibitors of soluble Adenylatzklase |
| 01/22/2009 | CA2695998A1 Novel heterocyclyl compounds |
| 01/22/2009 | CA2695004A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | CA2694475A1 Quinazolinamide derivatives |
| 01/22/2009 | CA2693880A1 Pyrimidine derivatives 934 |
| 01/22/2009 | CA2693594A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
| 01/22/2009 | CA2693444A1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 01/22/2009 | CA2693439A1 Pyridone gpr119 g protein-coupled receptor agonists |
| 01/22/2009 | CA2692713A1 Heterocyclic modulators of pkb |
| 01/21/2009 | EP2017266A1 Pyridazine derivatives and medicines containing the same as effective ingredients |
| 01/21/2009 | EP2017265A1 Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 01/21/2009 | EP2017263A1 Heteroarylamide lower carboxylic acid derivative |
| 01/21/2009 | EP2016942A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 01/21/2009 | EP2016072A1 Factor xa inhibitors |
| 01/21/2009 | EP2016071A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016069A1 Bis-pyridinium compounds |
| 01/21/2009 | EP2016068A1 Pyrazole derivatives and their use as pi3k inhibitors |
| 01/21/2009 | EP2016060A1 Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof |
| 01/21/2009 | EP2016058A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
| 01/21/2009 | EP2016055A1 Inhibitors of p38 map kinase |
| 01/21/2009 | EP2016049A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors |
| 01/21/2009 | EP2016047A1 Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 |
| 01/21/2009 | EP1904477B1 Indol-3-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists |
| 01/21/2009 | EP1863792B1 Atp competitive kinase inhibitors |
| 01/21/2009 | EP1664026B1 Mitotic kinesin inhibitors |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1626964B1 New benzimidazole derivatives |
| 01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/21/2009 | EP1549619B1 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 01/21/2009 | EP1531816B1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
| 01/21/2009 | EP1444211B1 Quinazoline derivatives as antitumor agents |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN101351456A Isoxazolines for controlling invertebrate pests |
| 01/21/2009 | CN101351453A 杂环酰胺化合物及其用途 The heterocyclic amide compounds and use thereof |
| 01/21/2009 | CN101351448A Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of COPD and asthma |
| 01/21/2009 | CN101351446A Novel fused pyrrole derivatives |
| 01/21/2009 | CN101348481A Argatroban and preparation thereof |
| 01/21/2009 | CN101348480A Novel synthetic method of loratadine |
| 01/21/2009 | CN101348467A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 01/21/2009 | CN101348463A Synthetic method of argatroban and intermediate thereof |
| 01/21/2009 | CN100453541C Substituted oxdiazole or triazole thioketone compounds, preparation and application thereof |
| 01/21/2009 | CN100453532C Substituted anthranilamides for controlling invertebrate pests |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453528C Non-symmetrical gelling agent |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
| 01/20/2009 | US7479502 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| 01/20/2009 | US7479496 Substituted spiro azabicyclics as modulators of chemokine receptor activity |
| 01/20/2009 | US7479495 N-heterocyclic inhibitors of TNF-α expression |
| 01/20/2009 | US7479494 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 01/20/2009 | US7479488 Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions |
| 01/20/2009 | US7479471 Applying to plants, seeds |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2499698C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 01/20/2009 | CA2477839C Nitrogen containing heterocyclic compounds and medicines containing the same |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2376676C Respiratory syncytial virus replication inhibitors |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2344411C 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 01/20/2009 | CA2339961C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2322204C 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents |
| 01/20/2009 | CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/15/2009 | WO2009009633A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/15/2009 | WO2009009550A1 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | WO2009009501A2 Non-basic melanin concentrating hormone receptor-1 antagonists and methods |
| 01/15/2009 | WO2009009411A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/15/2009 | WO2009009059A1 Spiro compounds as antagonists of tgf-beta |
| 01/15/2009 | WO2009008913A2 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/15/2009 | WO2009008905A1 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| 01/15/2009 | WO2009008371A1 Di(arylamino)aryl compound |
| 01/15/2009 | WO2009007753A2 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |
| 01/15/2009 | WO2009007747A2 Hydantoin derivatives used as mmp12 inhibitors |
| 01/15/2009 | WO2009007420A1 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides |
| 01/15/2009 | WO2009007419A1 Novel bronchodilating isoquinoline carbamates |
| 01/15/2009 | WO2009007418A1 Novel bronchodilating isoquinoline amides |
| 01/15/2009 | WO2009007399A1 New compounds as hsp90 inhibitors |
| 01/15/2009 | WO2009007390A2 2-pyraz inylbenz imidazole derivatives as receptor tyrosine kinase inhibitors |
| 01/15/2009 | WO2009007098A1 Isothiazole and pyrazole derivatives as fungicides |
| 01/15/2009 | WO2008125342A3 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals |
| 01/15/2009 | WO2008124083A3 Aurora kinase modulators and method of use |
| 01/15/2009 | WO2008089005A3 Renin inhibitors |
| 01/15/2009 | WO2007114827A8 Substituted heterocyclic compounds and methods of use |
| 01/15/2009 | US20090018339 Process For Preparing Crystalline Form A Of Lansoprazole |
| 01/15/2009 | US20090018338 Treatment of CRTH2-Mediated diseases and conditions |
| 01/15/2009 | US20090018177 Propane-1,3-Dione Derivative or Salt Thereof |
| 01/15/2009 | US20090018171 Imidazole derivatives |
| 01/15/2009 | US20090018170 5-lipoxygenase-activating protein (flap) inhibitors |